VCHSR
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
VCHSR is a drug used in scientific research which acts as a selective antagonist of the cannabinoid receptor CB 1 . It is derived from the widely used CB 1 antagonist rimonabant, and has similar potency and selectivity for the CB 1 receptor, but has been modified to remove the hydrogen bonding capability in the C-3 substituent region, which removes the inverse agonist effect that rimonabant produces at high doses, so that VCHSR instead acts as a neutral antagonist, blocking the receptor but producing no physiological effect of its own.
VCHSR is a drug used in scientific research which acts as a selective antagonist of the cannabinoid receptor CB 1 . It is derived from the widely used CB 1 antagonist rimonabant, and has similar potency and selectivity for the CB 1 receptor, but has been modified to remove the hydrogen bonding capability in the C-3 substituent region, which removes the inverse agonist effect that rimonabant produces at high doses, so that VCHSR instead acts as a neutral antagonist, blocking the receptor but producing no physiological effect of its own.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370372267 under CC BY-SA 4.0; modifications have been made.